Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GNTA

Genenta Science (GNTA)

Genenta Science SPA

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNTA

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
06/05/2024	12h25	GlobeNewswire Inc.	Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider	NASDAQ:GNTA	Genenta Science SPA
12/02/2024	22h05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GNTA	Genenta Science SPA
08/02/2024	11h00	GlobeNewswire Inc.	Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors	NASDAQ:GNTA	Genenta Science SPA
20/10/2023	22h15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNTA	Genenta Science SPA
06/09/2023	13h00	GlobeNewswire Inc.	Genenta to Present at Upcoming Scientific and Investor Conferences	NASDAQ:GNTA	Genenta Science SPA
28/07/2023	09h00	GlobeNewswire Inc.	Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments	NASDAQ:GNTA	Genenta Science SPA
29/06/2023	13h00	GlobeNewswire Inc.	The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma	NASDAQ:GNTA	Genenta Science SPA
25/05/2023	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNTA	Genenta Science SPA
16/05/2023	13h00	GlobeNewswire Inc.	Genenta to Provide Update on Lead Product Temferon™	NASDAQ:GNTA	Genenta Science SPA
12/05/2023	23h13	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:GNTA	Genenta Science SPA
01/05/2023	22h06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
26/04/2023	13h00	GlobeNewswire Inc.	Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing	NASDAQ:GNTA	Genenta Science SPA
21/04/2023	23h23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:GNTA	Genenta Science SPA
10/03/2023	22h49	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
10/02/2023	12h10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GNTA	Genenta Science SPA
01/02/2023	23h29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
22/12/2022	22h12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
27/10/2022	00h45	TipRanks	Maxim Group Remains a Buy on Genenta Science SpA Sponsored ADR (GNTA)	NASDAQ:GNTA	Genenta Science SPA
25/10/2022	23h14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
03/10/2022	13h17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
25/07/2022	12h00	GlobeNewswire Inc.	AmCham Italy and Genenta Science Announce the Bowling Green Bull Initiative	NASDAQ:GNTA	Genenta Science SPA
14/06/2022	23h12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
15/06/2009	16h47	PR Newswire (US)	The following is an investment opinion release issued by EmergingStockReport.com	NASDAQ:GNTA
15/05/2009	16h48	PR Newswire (US)	Stock Alerts on Market Movers: NGRN, RMBS, NVLS, LVS, GNTA, AN; Issued by Beacon Equity	NASDAQ:GNTA
07/03/2009	01h36	Dow Jones News	Genta: FDA Favors Clinical Trial For Leukemia Drug Genasense	NASDAQ:GNTA	Genta Inc.
07/03/2009	00h34	Business Wire	FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory ...	NASDAQ:GNTA	Genenta Science SPA
13/02/2009	22h10	Business Wire	Genta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA	Genenta Science SPA
07/01/2009	19h02	PR Newswire (US)	Beacon Equity Issues Technical Trade Alerts on Newsworthy Market Movers: WLT, SSCC, FNSR, CHTR, STSI, GNTA	NASDAQ:GNTA
15/09/2008	14h05	PR Newswire (US)	Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma	NASDAQ:GNTA
07/08/2008	14h00	PR Newswire (US)	Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA

Showing the most relevant articles for your search:NASDAQ:GNTA

1 2 3 4 5 6 7 8 9 10 Next >>

Deutsche Lufthansa

Invesco QQQ Trust Series 1

JP Morgan Chase

BNP Paribas (QX)

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen